Twelve months later, Miller is healthy and preparing to host her family's holiday gathering. A regimen of biological drugs ...

A growing body of evidence suggests GLP-1 receptor agonists may improve survival as well as reduce chemotherapy-related toxicities in women with breast cancer.

The annual San Antonio Breast Cancer Symposium was held from Dec. 9 to 12 in San Antonio. Attendees included medical ...

Nasal cancer, a rare but increasing cancer, affects men more than women. It originates in the nasal cavity or sinuses. Risk ...

The 2025 San Antonio Breast Cancer Symposium brought plenty of data and bold new ideas to the thousands of clinicians, ...

Can the immune system cure cancer? Dr. Patrick Soon-Shiong discusses a paradigm shift using NK cells to treat tumors without ...

Most premenopausal women with early breast cancer accepted GnRHa therapy during chemotherapy to preserve ovarian function, ...

In a Phase 1 trial, women responded well to the novel vaccine. More research is needed to determine whether it can stop the ...

For patients living with HER2-positive metastatic breast cancer, the recent FDA approval of trastuzumab deruxtecan (brand ...

A research breakthrough in Western Australia has helped explain the mystery of historically low survival rates among ...

In premenopausal women with early breast cancer, survival is not affected by fertility preservation procedures, researchers report.

The test, a cell-free DNA test, uses a sample of the mother's blood to screen for certain conditions in the developing fetus ...